Table 2.
Promoter | Targeted gene | Mechanism | Tumorigenesis | Reference |
---|---|---|---|---|
Ovgp-1 | SV40 TAg | Inactivation of p53 and pRb | Neoplastic lesions in the fallopian tube resembling human serous tubal intraepithelial carcinoma (STIC) a potential precursor of ovarian HGSC | Miyoshi et al., 2002 [153] Sherman-Baust et al., 2014 [154] |
MISIIR (Amhr2-Cre) | Dicer-/-& Pten-/- | Disruption of PI3K and AKT pathways (increased phosphorylation of AKT, STMN1- stathmin) and BIRC5 -survivin) | High grade serous carcinomas from the oviduct. Tumors spread to the ovary and metastasize throughout the abdominal cavity. Upregulated expression of cytokeratin 14, 17, and 8, E-cadherin, CA125 | Kim et al., 2012 [155] |
Pax8-Cre | Brca 1 or Brca 2-/-, p53-/-, Pten-/- | Alteration in PTEN/PI3K pathway | Serous tubal intraepithelial carcinoma (precursor lesion to ovarian HGSC and peritoneal carcinomas). Upregulated expression of including cytokeratin-8, STMN1, PAX2, P53, Ki-67, and CA-125 | Perets et al., 2013 [160] |
AdCre | Pik3ca & Pten-/- | Disruption of PI3K and AKT pathways (increased phosphorylation of AKT) | Serous papillary hyperplasia of the ovaries | Kinross et al., 2012 [156] |
AdCre |
Pten-/- & Apc-/-& p53-/- |
Disruption of PI3K/AKT/mTOR pathway | High grade metastatic ovarian carcinomas CD24+ cells showed greater tumor initiation rates |
Burgos-Ojeda et al., 2015 [161] |
STIC, serous tubal intraepithelial carcinoma; HGSC, high-grade serous carcinoma; MISIIR, Müllerian inhibiting substance type II receptor; PAX2 and PAX8, transcription factors; CA-125, cancer antigen 125; Ki-67, a nuclear protein expressed in proliferating mammalian cells; PI3K, phosphatidylinositol 3-kinase; AKT, serine/threonine kinase, mTOR, mammalian target of rapamycin; PTEN, phosphatase and tensin homolog; Dicer, endoribonuclease